Lifelong Monitoring: Staying Ahead of Changes
At a Glance
Children with Carvajal syndrome need lifelong, individualized monitoring because heart rhythm problems and scarring can develop before pumping strength falls. ECGs, Holter monitors, echocardiograms, cardiac MRI, and family DSP testing help clinicians detect changes early.
Monitoring Carvajal syndrome is a lifelong commitment. Because the condition is progressive and can change as your child grows, regular check-ups are not just about checking current health—they are about detecting tiny changes before they become problems.
Your Child’s Care Team
Managing this rare condition requires a team of specialists who work together. This “medical neighborhood” typically includes:
- Pediatric Electrophysiologist: A heart rhythm specialist who monitors for dangerous heartbeats (arrhythmias) [1].
- Heart Failure Specialist: A cardiologist focused on the heart’s structure and pumping ability [2].
- Dermatologist: To help manage the thickening skin on the hands and feet [3].
- Genetic Counselor: To help you understand the DSP mutation and what it means for the rest of your family [4].
The Cardiac Monitoring Toolkit
A standard cardiac evaluation for Carvajal syndrome involves several tests. While a physical exam is important, these tools provide a look “under the hood.” An example schedule might be every 6 to 12 months, depending heavily on the child’s age, genotype, and symptoms [5].
- 12-Lead ECG: A quick snapshot of the heart’s electrical activity. Doctors look for specific patterns, such as T-wave inversions or low-voltage signals, which can be early signs of heart muscle changes [2][6].
- 24-Hour Holter Monitor: A wearable device that records every heartbeat for a full day. It is used to detect “silent” irregular rhythms, such as premature ventricular contractions (PVCs) or brief bursts of rapid heartbeats (nonsustained VT), which might not happen during a short office visit [7][1].
- Echocardiogram: A heart ultrasound that shows the heart’s size and how well it pumps blood (ejection fraction) [2].
Why Cardiac MRI is Essential
While echocardiograms are helpful, they are often used alongside a Cardiac MRI (CMR) with Late Gadolinium Enhancement (LGE), which is an important complementary tool for monitoring this specific condition [8][9].
- Detecting Early Fibrosis: In many patients with DSP mutations, the heart muscle begins to develop scarring (fibrosis) before the heart actually starts to weaken. An echocardiogram usually cannot see this scar tissue, but a CMR can [8]. In one research cohort of patients with pathogenic DSP variants, 35% of those who underwent imaging had visible LGE even though their heart’s pumping function still looked normal [8].
- Identifying “Hot Phases”: Some children experience episodes that feel like a heart infection (myocarditis), often called a “hot phase.” These episodes can cause chest pain and a rise in heart enzymes (troponin) [2][8]. A CMR can detect active inflammation and swelling during these phases, helping doctors adjust treatment immediately to protect the heart [10].
Cascade Genetic Screening: Protecting the Family
Because Carvajal syndrome is a genetic condition caused by a mutation in the DSP gene, finding it in one child has implications for the whole family. This process is called cascade screening [11].
- Testing Siblings: Even if a sibling has normal hair and skin, they should be tested for the family’s specific DSP mutation. Because the condition is recessive, a sibling might be a “carrier” (one gene) or might have both genes but not yet show symptoms [12][4].
- Testing Parents: Both biological parents are typically carriers of the gene. While carriers usually do not have symptoms, confirming their status helps clarify the genetic risk for future children or other relatives [11]. Testing positive for a variant requires genetic counseling, as some single variants can have cardiac implications.
- The Power of Knowledge: Relatives who test negative for the known familial variants generally do not need ongoing cardiac monitoring for this condition [13]. Those who test positive can begin their own monitoring early, ensuring they stay ahead of any potential heart changes [11][14].
By keeping up with this rigorous monitoring schedule, you and your medical team can make informed decisions about medications, activity, and whether specialized devices like an ICD are needed [5][7].
Common questions in this guide
How often should a child with Carvajal syndrome have heart tests?
What can a cardiac MRI show in Carvajal syndrome?
What is a hot phase, and what should we do if it happens?
Why does my child need a Holter monitor if the office ECG is normal?
Who in the family should have genetic testing after a DSP mutation is found?
Can a sibling have Carvajal syndrome without hair or skin changes?
Which specialists usually monitor a child with Carvajal syndrome?
One line in your results can change your plan.
For relatives, a test result for the known familial variant can help decide whether ongoing cardiac monitoring is needed. We check your results against the latest research to help you prepare for what’s next.
Get notified when new evidence is published on Carvajal syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Genotype and cardiac outcome in patients with cardiocutaneous syndrome (Naxos disease variant: Carvajal syndrome).
Binfadel M, Aleem MU, Alhabdan M, et al.
Orphanet journal of rare diseases 2025; (20(1)):137 doi:10.1186/s13023-025-03612-8.
PMID: 40108711 - 2
Desmoplakin Cardiomyopathy in Pediatric Patients: A Distinct, Underrecognized Cohort of Arrhythmogenic Cardiomyopathy.
Choi NH, Cherny S, Berul CI, et al.
Circulation. Arrhythmia and electrophysiology 2024; (17(11)):e013114 doi:10.1161/CIRCEP.124.013114.
PMID: 39523938 - 3
Carvajal Syndrome- A Variant of Naxos Disease: A Case Report.
Mandal KD, Shrestha PN, Ghimire A, et al.
JNMA; journal of the Nepal Medical Association 2022; (60(246)):187-191 doi:10.31729/jnma.7102.
PMID: 35210635 - 4
Desmoplakin Cardiomyopathy Presenting as Recurrent Myocarditis Treated With Immunosuppression.
Abdaem J, Leader N, Ballantyne BA, et al.
JACC. Case reports 2025; (30(27)):104927 doi:10.1016/j.jaccas.2025.104927.
PMID: 40767829 - 5
Arrhythmic risk assessment in genotyped families with arrhythmogenic right ventricular cardiomyopathy.
Protonotarios A, Anastasakis A, Panagiotakos DB, et al.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2016; (18(4)):610-6 doi:10.1093/europace/euv061.
PMID: 25825460 - 6
Clinical features and outcomes in carriers of pathogenic desmoplakin variants.
Gasperetti A, Carrick RT, Protonotarios A, et al.
European heart journal 2025; (46(4)):362-376 doi:10.1093/eurheartj/ehae571.
PMID: 39288222 - 7
Diagnostic Criteria and Disease Staging for Desmoplakin Cardiomyopathy.
Smith E, Gasperetti A, Carrick RT, et al.
medRxiv : the preprint server for health sciences 2025; doi:10.1101/2025.06.16.25329734.
PMID: 40666337 - 8
Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct From Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
Smith ED, Lakdawala NK, Papoutsidakis N, et al.
Circulation 2020; (141(23)):1872-1884 doi:10.1161/CIRCULATIONAHA.119.044934.
PMID: 32372669 - 9
Case report: Multiple biventricular aneurysms in arrhythmogenic cardiomyopathy.
Lin J, Lu Z, Lin M, et al.
Frontiers in cardiovascular medicine 2022; (9()):1034703 doi:10.3389/fcvm.2022.1034703.
PMID: 36762301 - 10
Recurrent myocarditis as a clinical gateway to desmoplakin cardiomyopathy: a case report.
Reyes T RE, Vargas-Hernández DA, Cañón DP, Figueroa JF
European heart journal. Case reports 2026; (10(3)):ytag062 doi:10.1093/ehjcr/ytag062.
PMID: 41788433 - 11
Clinical care of family members of patients with dilated cardiomyopathy.
Verdonschot JAJ, Kaski JP, Asselbergs FW, et al.
European heart journal 2025; (46(43)):4569-4582 doi:10.1093/eurheartj/ehaf571.
PMID: 40902100 - 12
Myocarditis Revealing a Pathogenic Desmoplakin (DSP) Variant: Implications for Genetic Testing Pathways.
Reka B, Dungu JN
Cureus 2026; (18(9)):e116569 doi:10.7759/cureus.116569.
PMID: 42903300 - 13
Cascade testing for inherited cardiac conditions: Risk perception and screening after a negative genetic test result.
Fusco KM, Hylind RJ, Cirino AL, et al.
Journal of genetic counseling 2022; (31(6)):1273-1281 doi:10.1002/jgc4.1602.
PMID: 35763674 - 14
Issues and Challenges in Diagnostic Sequencing for Inherited Cardiac Conditions.
Walsh R, Cook SA
Clinical chemistry 2017; (63(1)):116-128 doi:10.1373/clinchem.2016.254698.
PMID: 27879323
This page provides general information about lifelong monitoring for Carvajal syndrome and is for informational purposes only; it does not constitute medical advice. Your child’s cardiology, genetics, and dermatology team should personalize testing, follow-up, and treatment decisions.